Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

43 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immuno markers in newly diagnosed glioblastoma patients underwent Stupp protocol after neurosurgery: a retrospective series.
Gurrieri L, Mercatali L, Ibrahim T, Fausti V, Dall'Agata M, Riva N, Ranallo N, Pasini G, Tazzari M, Foca F, Bartolini D, Riccioni L, Cavatorta C, Morigi FP, Bulgarelli J, Cocchi C, Ghini V, Tosatto L, Martinelli G, Pession A, Ridolfi L. Gurrieri L, et al. Among authors: dall agata m. J Neurooncol. 2023 Aug;164(1):55-64. doi: 10.1007/s11060-023-04357-9. Epub 2023 Aug 16. J Neurooncol. 2023. PMID: 37584750 Free PMC article.
Identification of palliative care needs and prognostic factors of survival in tailoring appropriate interventions in advanced oncological, renal and pulmonary diseases: a prospective observational protocol.
Valenti V, Rossi R, Scarpi E, Dall'Agata M, Bassi I, Cravero P, La Manna G, Magnoni G, Marchello M, Mosconi G, Nanni O, Nava S, Pallotti MC, Rapposelli IG, Ricci M, Scrivo A, Spazzoli A, Valenti D, Zambianchi L, Caraceni A, Maltoni M. Valenti V, et al. Among authors: dall agata m. BMJ Open. 2023 May 30;13(5):e065971. doi: 10.1136/bmjopen-2022-065971. BMJ Open. 2023. PMID: 37253494 Free PMC article.
Carboplatin and paclitaxel plus avelumab compared with carboplatin and paclitaxel in advanced or recurrent endometrial cancer (MITO END-3): a multicentre, open-label, randomised, controlled, phase 2 trial.
Pignata S, Scambia G, Schettino C, Arenare L, Pisano C, Lombardi D, De Giorgi U, Andreetta C, Cinieri S, De Angelis C, Priolo D, Casanova C, Rosati M, Greco F, Zafarana E, Schiavetto I, Mammoliti S, Cecere SC, Salutari V, Scalone S, Farolfi A, Di Napoli M, Lorusso D, Gargiulo P, Califano D, Russo D, Spina A, De Cecio R, Chiodini P, Perrone F; MITO investigators. Pignata S, et al. Lancet Oncol. 2023 Mar;24(3):286-296. doi: 10.1016/S1470-2045(23)00016-5. Epub 2023 Feb 14. Lancet Oncol. 2023. PMID: 37052965 Clinical Trial.
Prognostication in palliative radiotherapy-ProPaRT: Accuracy of prognostic scores.
Maltoni M, Scarpi E, Dall'Agata M, Micheletti S, Pallotti MC, Pieri M, Ricci M, Romeo A, Tenti MV, Tontini L, Rossi R. Maltoni M, et al. Among authors: dall agata m. Front Oncol. 2022 Aug 16;12:918414. doi: 10.3389/fonc.2022.918414. eCollection 2022. Front Oncol. 2022. PMID: 36052228 Free PMC article.
Achilles tendon ultrasonography in familial hypercholesterolemia: A sub-study of the LIpid transPort disorders Italian GEnetic Network (LIPIGEN).
Baragetti A, Casula M, Scarinzi P, Ristè F, Scicali R, Biolo M, Lugari S, Dall'Agata M, Gazzotti M, Olmastroni E, Alieva AS, Nascimbeni F; ACTUS-FH LIPIGEN Substudy. Baragetti A, et al. Among authors: dall agata m. J Intern Med. 2022 May;291(5):702-704. doi: 10.1111/joim.13421. Epub 2021 Dec 16. J Intern Med. 2022. PMID: 34875114 Free PMC article. No abstract available.
Patients with multiple myeloma referred for palliative care consultation: from retrospective analysis to future directions to improve clinical outcomes.
Pallotti MC, Rossi R, Scarpi E, Dall'Agata M, Ricci M, Ceccolini M, Ronconi S, Valenti V, Maltoni M, Martinelli G, Cerchione C. Pallotti MC, et al. Among authors: dall agata m. Support Care Cancer. 2022 Mar;30(3):2293-2298. doi: 10.1007/s00520-021-06560-8. Epub 2021 Oct 31. Support Care Cancer. 2022. PMID: 34718886 Free PMC article.
Phase II study of liposomal doxorubicin, docetaxel and trastuzumab in combination with metformin as neoadjuvant therapy for HER2-positive breast cancer.
Rocca A, Cortesi P, Cortesi L, Gianni L, Matteucci F, Fantini L, Maestri A, Giunchi DC, Cavanna L, Ciani R, Falcini F, Bagni A, Meldoli E, Dall'Agata M, Volpi R, Andreis D, Nanni O, Curcio A, Lucchi L, Amadori D, Fedeli A. Rocca A, et al. Among authors: dall agata m. Ther Adv Med Oncol. 2021 Feb 9;13:1758835920985632. doi: 10.1177/1758835920985632. eCollection 2021. Ther Adv Med Oncol. 2021. PMID: 33613693 Free PMC article.
43 results